Steatohepatitis and apoptosis: Therapeutic implications

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1718-1719

  Feldstein, Ariel ^b   Gores, Gregory J ^a  

^a Mayo Clinic   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOLIC FATTY LIVER; APOPTOSIS; DISEASE COURSE; EDITORIAL; FATTY LIVER; HUMAN; KUPFFER CELL; LIVER CELL; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; APOPTOSIS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NF-KAPPA B; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 4544334260     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40573.x     Document Type: Editorial

References (17)

1. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000;108:567-74.
2. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver biology and disease. Prog Liver Dis 1995;13:1-35.
3. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001;34:254-60.
4. Natori S, Rust C, Stadheim LM, et al. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:248-53.
5. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-43.
6. Ribeiro PS, Cortez-Pinto H, Sola S, et al. Hepatocyte apoptosis, expression of death receptors and activation of NF-kappaB in the liver of non-alcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; in press.
7. Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52.
8. Feldstein AE, Canbay A, Guicciardi ME, et al. Diet associated hepatic steatosis sensitizes to fas mediated liver injury in mice. J Hepatol 2003;39:978-83.
9. Feldstein AE, Werneburg N, Canbay A, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-a expression via a lysosomal pathway. Hepatology 2004; in press.
10. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses., Annu Rev Immunol 1998;16:225-60.
11. Green DR. Death and NF-kappaB in T cell activation: Life at the edge. Molecular Cell 2003;11:551-52.
12. Faouzi S, Burckhardt BE, Hanson JC, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-82.
13. Canbay A, Guicciardi ME, Higuchi H, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003;112:152-9.
14. Canbay A, Taimr P, Torok N, et al. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Laboratory Investigation 2003;83:655-63.
15. Fiorucci S, Mencarelli A, Palazzetti B, et al. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci USA 2001;98:2652-57.
16. Canbay A, Feldstein A, Baskin-Bey E, et al. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 2004;308:1191-96.
17. Ghibelli L, Mengoni F, Lichtner M, et al. Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain. Biochem Pharmacol 2003;66:1505-12.